This website uses cookies to identify your browser when interacting with the website. By browsing this website, you agree to this website's use of cookies and related privacy policies.

公司理念

禾榮科技

通過AB-BNCT創新治療方案 讓病人獲得治癒、維持生活品質

Responsibilities of Audit Committee

Heron's Audit Committee is composed of all independent directors, with no fewer than 3 members. One member serves as the convener, and at least one member must have expertise in accounting or finance. Independent directors serve a term of 3 years and may be re-elected. The committee meets at least once per quarter and may convene additional meetings as needed.

The Audit Committee’s annual work priorities
  • Fair Presentation of Financial Statements

    • Review of the financial report for the 2024 and the quarterly report for the 2025.
  • Selection (dismissal), independence and performance of certified accountants.

    • Review of the competence and independence of the certified public accountant for the year 2025.
    • Review of the audit fees paid to the CPA.
  • Effective implementation of the company's internal control.

    • Review of the internal audit report, Statement of Internal Control for the Year 2024 , and the revision of the internal control system.
  • The company follows relevant laws and regulations.

Authority of Audit Committee
    • Formulating or amending the internal control system in accordance with Article 14-1 of the Securities and Exchange Act
    • Evaluating the effectiveness of the internal control system.
    • Formulating or amending the procedures for handling significant financial and business activities, such as acquiring or disposing of assets, engaging in derivative transactions, lending funds to others, providing endorsements or guarantees, in accordance with Article 36-1 of the Securities and Exchange Act.
    • Matters involving the interests of directors.
    • Significant asset or derivative transactions.
    • Significant lending of funds, endorsements, or guarantees.
    • Fundraising, issuance, or private placement of equity-type securities.
    • Appointment, dismissal, or remuneration of the certified public accountant.
    • Appointment or dismissal of the financial, accounting, or internal audit supervisors.
    • The annual financial report signed or stamped by the chairman, managers, and accounting supervisors, and the second-quarter financial report audited and certified by an accountant.
    • Review risk management policy, procedures, organization, and supervise the implementation of risk management.
    • Other significant matters as required by the company or regulatory authorities.
Member of Audit Committee
Title Name Election date Principal Academic Qualifications Principal Work Experiences
Chairperson Chyan Yang 2025/01/14
  • Ph.D. in Computer Science & Engineering, University of Washington.
  • Ph.D. in Computer Science & Engineering, University of Washington.
  • Professor, College of Management, National Yang Ming Chiao Tung University.
  • Executive Director of EMBA at National Yang-Ming Chiao Tung University.
Member Jay Hsieh 2025/01/14
  • Master's degree in Executive Business Administration from National Tsing Hua University.
  • Chairperson of Bojal Co., Ltd
  • Chairperson of Izo Health Care Co., Ltd
Member Chih-Chieh Lin 2025/01/14
  • S.J.D. vs LLM. Duke University School of Law&Master's degree in Executive Business Administration from National Taiwan University
  • Chairperson of the Financial Ombudsman Institution
  • Member of the National Conference on Judicial Reform
  • Deputy Dean of Office of International Affairs, National Chiao Tung University
  • Chief and Vice President of National Yang Ming Chiao Tung University School of Law
  • Deputy Editor-in-Chief of The Taiwan Law Review
  • Attorney
  • Member of Human Rights Committee of the Ministry of Justice
  • Member of Examination for the Selection of Prosecutors
  • Member of Ministry of Foreign Affairs, Transportation and Economic Affairs Integrity
  • Advisory Committee Member of the Mainland Affairs Council
  • Member of Central Integrity Committee/li>
  • Member of Agency Against Corruption Ministry of Justice
  • Member of Agency Against Corruption Ministry of Justice
  • Member of National Health Insurance Dispute Mediation Committee
  • Member of Attorney Qualification Review Committee
  • Member of Ministry of Amend Justice Criminal Law
  • Member of Defense Ministry's Integrity Committee
  • Member of Lawyer Disciplinary Review Committee
  • Member of Judicial Evaluation Committee
  • Member of Prosecutorial Retrial Committee
  • Member of Judicial Yuan Training Committee
The Audit Committee's Operational Status
Meeting Date Agenda Items Resolution
2025/03/27
  • The Company’s 2024 annual business report and financial statements.
  • To approve the 2024 loss offset proposal.
  • To approve the Company’s internal audit report on internal control self-assessment and Internal Control System Statement for 2024.
  • Established the Company's "Plan to Enhance the Ability to Prepare Financial Reports".
  • Establishing the Company's "Risk Management Policies and Procedures".
  • Proposal to amend the "Policy on Inventory Obsolescence and Valuation Allowance".
  • Proposal to amend the Company’s internal control system and implementation rules for internal audit.
  • To approve the evaluation on the independence and suitability of the auditing CPAs.
  • To approve the engagement and compensation of the auditing CPAs for the year of 2025.
  • Execution of a sales agreement with a related party.

All attending Directors unanimously approved this motion.

114/05/06
  • The Company’s 2025 Q1 financial statements.
  • To approve the Company’s internal audit report on internal control self-assessment and Internal Control System Statement.
  • To approve the corporate governance evaluation self-assessment report.
  • Proposal to amend the Company’s internal control system and implementation rules for internal audit.
  • The Company's financial forecast for the third quarter of 2025.
  • Appointment of the Company's Chief Corporate Governance Officer.

All attending Directors unanimously approved this motion.

2025/07/24
  • The Company’s 2025 Q2 financial statements.
  • The Company's plan to issue new shares for cash capital increase.
  • Revise the sales agreement with a related party.

All attending Directors unanimously approved this motion.

The independent directors communicate with the chief of internal audit executive (CAE) and the independent auditor at the regular Audit Committee meetings and in the separate meetings.
      • For special or significant matters, the independent directors can access the CAE or independent auditor for discussion anytime.
        • Summary of the meeting agenda that was communicated between the independent directors and CAE is shown in the following :
go top top go top top